UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 175

Sortiert nach

Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients

Journal of immunology research, 2019-01, Vol.2019, p.8983903-10

2019

Volltextzugriff (PDF)

Enhanced Regeneration and Hepatoprotective Effects of Interleukin 22 Fusion Protein on a Predamaged Liver Undergoing Partial Hepatectomy

Journal of Immunology Research, 2018-01, Vol.2018, p.5241526-12

2018

Volltextzugriff (PDF)

Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial

Journal of clinical oncology, 2021-09, Vol.39 (27), p.3002-3011

2021

Volltextzugriff (PDF)

Characterization of Gut Microbiota, Bile Acid Metabolism, and Cytokines in Intrahepatic Cholangiocarcinoma

Hepatology (Baltimore, Md.), 2020-03, Vol.71 (3), p.893-906

2020

Volltextzugriff (PDF)

Oncolytic adenovirus programmed by synthetic gene circuit for cancer immunotherapy

Nature communications, 2019-10, Vol.10 (1), p.4801-15, Article 4801

2019

Volltextzugriff (PDF)

Hsp90 middle domain phosphorylation initiates a complex conformational program to recruit the ATPase-stimulating cochaperone Aha1

Nature communications, 2019-06, Vol.10 (1), p.2574-2574, Article 2574

2019

Volltextzugriff (PDF)

Bruton tyrosine kinase degrader BP001 attenuates the inflammation caused by high glucose in raw264.7 cell

In vitro cellular & developmental biology. Animal, 2024, Vol.60 (6), p.667-677

2024

Volltextzugriff (PDF)

Transport of surfactant-facilitated multiwalled carbon nanotube suspensions in columns packed with sized soil particles

Environmental pollution (1987), 2014-09, Vol.192, p.36-43

2014

Volltextzugriff (PDF)

25(OH) D3 alleviate liver NK cytotoxicity in acute but not in chronic fibrosis model of BALB/c mice due to modulations in vitamin D receptor

BMC gastroenterology, 2020-04, Vol.20 (1), p.102-102, Article 102

2020

Volltextzugriff (PDF)

Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2015-05, Vol.61 (5), p.1579-1590

2015

Volltextzugriff (PDF)

The effects of surfactants and solution chemistry on the transport of multiwalled carbon nanotubes in quartz sand-packed columns

Environmental pollution (1987), 2013-11, Vol.182, p.269-277

2013

Volltextzugriff (PDF)

Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo

Cell death & disease, 2020-02, Vol.11 (2), p.118, Article 118

2020

Volltextzugriff (PDF)

Intestinal Candida albicans Promotes Hepatocarcinogenesis by Up-Regulating NLRP6

Frontiers in microbiology, 2022-03, Vol.13, p.812771-812771

2022

Volltextzugriff (PDF)

The impact of receptor-binding domain natural mutations on antibody recognition of SARS-CoV-2

Signal transduction and targeted therapy, 2021-03, Vol.6 (1), p.132-3, Article 132

2021

Volltextzugriff (PDF)

Spotlight on NLRP6 and Tumor Research Situation: A Potential Cancer Participant

Journal of Immunology Research, 2023-06, Vol.2023, p.6613064-12

2023

Volltextzugriff (PDF)

A race to uncover a panoramic view of primary liver cancer

Cancer biology & medicine, 2017-11, Vol.14 (4), p.335-340

2017

Volltextzugriff (PDF)

MARCH6 promotes hepatocellular carcinoma development through up-regulation of ATF2

BMC cancer, 2021-07, Vol.21 (1), p.1-827, Article 827

2021

Volltextzugriff (PDF)

Comparison of hepatitis B virus reactivation in hepatocellular carcinoma patients who received tyrosine kinase inhibitor alone or together with programmed cell death protein-1 inhibitors

Hepatology international, 2023-04, Vol.17 (2), p.281-290

2023

Volltextzugriff (PDF)

Taurohyocholic acid acts as a potential predictor of the efficacy of tyrosine kinase inhibitors combined with programmed cell death-1 inhibitors in hepatocellular carcinoma

Frontiers in pharmacology, 2024, Vol.15, p.1364924-1364924

2024

Volltextzugriff (PDF)

Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients

Hepatology international, 2023-06, Vol.17 (3), p.709-719

2023

Volltextzugriff (PDF)

Long-term outcomes of percutaneous cryoablation for patients with hepatocellular carcinoma within Milan criteria

PloS one, 2015-04, Vol.10 (4), p.e0123065-e0123065

2015

Volltextzugriff (PDF)

Reviewing immunopathology characteristics of SARS-CoV-2 for cancer entwisted with SARS-CoV-2

SAGE Open Medicine, 2021-01, Vol.9, p.2050312121989504-2050312121989504

2021

Volltextzugriff (PDF)

TKI or TKI combined with PD-1 inhibitors as second-line treatment for HCC patients after sorafenib failure

Frontiers in pharmacology, 2022-12, Vol.13, p.1026337-1026337

2022

Volltextzugriff (PDF)

Outcomes of ultrasound-guided percutaneous argon-helium cryoablation of hepatocellular carcinoma

Journal of hepato-biliary-pancreatic sciences, 2012-11, Vol.19 (6), p.674-684

2012

Volltextzugriff (PDF)

1 – 25 von 175

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(165)
Mit Volltextzugriff
(167)

Publikationsform

Sprache

Englisch
(164)
Japanisch
(12)
Chinesisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(132)
Life Sciences & Biomedicine
(115)
Humans
(59)
Hepatocellular Carcinoma
(45)
Oncology
(34)
Liver Cancer
(32)
Male
(32)
Female
(25)
Middle Aged
(20)
Cell Biology
(16)
Liver Neoplasms - Pathology
(16)
Patients
(16)
Carcinoma, Hepatocellular - Pathology
(15)
Gastroenterology & Hepatology
(15)
Physical Sciences
(15)
Prognosis
(14)
Proteins
(14)
Technology
(14)
Tumors
(14)
Biochemistry & Molecular Biology
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(3)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients

Enhanced Regeneration and Hepatoprotective Effects of Interleukin 22 Fusion Protein on a Predamaged Liver Undergoing Partial Hepatectomy

Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial

Characterization of Gut Microbiota, Bile Acid Metabolism, and Cytokines in Intrahepatic Cholangiocarcinoma

Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes

Oncolytic adenovirus programmed by synthetic gene circuit for cancer immunotherapy

Hsp90 middle domain phosphorylation initiates a complex conformational program to recruit the ATPase-stimulating cochaperone Aha1

Bruton tyrosine kinase degrader BP001 attenuates the inflammation caused by high glucose in raw264.7 cell

Transport of surfactant-facilitated multiwalled carbon nanotube suspensions in columns packed with sized soil particles

25(OH) D3 alleviate liver NK cytotoxicity in acute but not in chronic fibrosis model of BALB/c mice due to modulations in vitamin D receptor

Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma

The effects of surfactants and solution chemistry on the transport of multiwalled carbon nanotubes in quartz sand-packed columns

Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo

Intestinal Candida albicans Promotes Hepatocarcinogenesis by Up-Regulating NLRP6

The impact of receptor-binding domain natural mutations on antibody recognition of SARS-CoV-2

Spotlight on NLRP6 and Tumor Research Situation: A Potential Cancer Participant

A race to uncover a panoramic view of primary liver cancer

MARCH6 promotes hepatocellular carcinoma development through up-regulation of ATF2

Comparison of hepatitis B virus reactivation in hepatocellular carcinoma patients who received tyrosine kinase inhibitor alone or together with programmed cell death protein-1 inhibitors

Taurohyocholic acid acts as a potential predictor of the efficacy of tyrosine kinase inhibitors combined with programmed cell death-1 inhibitors in hepatocellular carcinoma

Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients

Long-term outcomes of percutaneous cryoablation for patients with hepatocellular carcinoma within Milan criteria

Reviewing immunopathology characteristics of SARS-CoV-2 for cancer entwisted with SARS-CoV-2

TKI or TKI combined with PD-1 inhibitors as second-line treatment for HCC patients after sorafenib failure

Outcomes of ultrasound-guided percutaneous argon-helium cryoablation of hepatocellular carcinoma

Suchergebnisse filtern